Allogeneic hematopoietic stem cell transplantation could overcome the poor prognosis of DNMT3AmutNPM1mutFLT3-ITDmut in acute myeloid leukemia: real-world multicenter analysis in China
Frontiers of Medicine · 2025
DOI: 10.1007/s11684-024-1091-5 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Frontiers of Medicine, 2025. Verfasst von Wenxuan Huo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Ke…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Hematopoietic Stem Cell Transplantation, DNA (Cytosine-5-)-Methyltransferases, Nuclear Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, 1000…
- National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Collaborative Innovation C…
- Jiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou, 215006, China.
- Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine…
- Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
- Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, 10044, China.
Zitieren
APA
Huo, W., Shen, Y., Huang, J., Yang, Y., Fan, S., Zhao, X., Wen, Q., Wang, L., Jiang, C., Cao, Y., Mo, X., Xu, Y., & Hu, X. (2025). Allogeneic hematopoietic stem cell transplantation could overcome the poor prognosis of DNMT3AmutNPM1mutFLT3-ITDmut in acute myeloid leukemia: real-world multicenter analysis in China. Frontiers of Medicine. https://doi.org/10.1007/s11684-024-1091-5
Vancouver
Huo W, Shen Y, Huang J, Yang Y, Fan S, Zhao X, et al. Allogeneic hematopoietic stem cell transplantation could overcome the poor prognosis of DNMT3AmutNPM1mutFLT3-ITDmut in acute myeloid leukemia: real-world multicenter analysis in China. Frontiers of Medicine. 2025. doi:10.1007/s11684-024-1091-5
BibTeX
@article{Huo2025,
author = {Huo, Wenxuan and Shen, Yifan and Huang, Jiayu and Yang, Yang and Fan, Shuang and Zhao, Xiaosu and Wen, Qi and Wang, Luxiang and Jiang, Chuanhe and Cao, Yang and Mo, Xiaodong and Xu, Yang and Hu, Xiaoxia},
title = {Allogeneic hematopoietic stem cell transplantation could overcome the poor prognosis of DNMT3AmutNPM1mutFLT3-ITDmut in acute myeloid leukemia: real-world multicenter analysis in China},
journal = {Frontiers of Medicine},
year = {2025},
doi = {10.1007/s11684-024-1091-5}
}
EUVIMED